Schizophrenia: an integrative approach to modelling a complex disorder
- PMID: 16699601
- PMCID: PMC1449879
Schizophrenia: an integrative approach to modelling a complex disorder
Abstract
The discovery of candidate susceptibility genes for schizophrenia and the generation of mice lacking proteins that reproduce biochemical processes that are disrupted in this mental illness offer unprecedented opportunities for improved modelling of this complex disorder. Several lines of evidence indicate that obstetrical complications, as well as fetal or neonatal exposure to viral infection, are predisposing events for some forms of schizophrenia. These environmental events can be modelled in animals, resulting in some of the characteristic features of schizophrenia; however, animal models have yet to be developed that encompass both environmental and genetic aspects of this mental illness. A large number of candidate schizophrenia susceptibility genes have been identified that encode proteins implicated in the regulation of synaptic plasticity, neurotransmission, neuronal migration, cell adherence, signal transduction, energy metabolism and neurite outgrowth. In support of the importance of these processes in schizophrenia, mice that have reduced levels or completely lack proteins that control glutamatergic neurotransmission, neuronal migration, cell adherence, signal transduction, neurite outgrowth and synaptic plasticity display many features reminiscent of schizophrenia. In the present review, we discuss strategies for modelling schizophrenia that involve treating mice that bear these mutations in a variety of ways to better model both environmental and genetic factors responsible for this complex mental illness according to a "two-hit hypothesis." Because rodents are able to perform complex cognitive tasks using odour but not visual or auditory cues, we hypothesize that olfactory-based tests of cognitive performance should be used to search for novel therapeutics that ameliorate the cognitive deficits that are a feature of this devastating mental disorder.
La découverte de gènes candidats pour la prédisposition à la schizophrénie et la production de souris sans protéines reflétant les processus biochimiques perturbés dans le cas de cette maladie mentale offrent des possibilités sans précédent d'améliorer la modélisation de ce trouble complexe. Plusieurs sources de données probantes indiquent que des complications obstétriques et l'exposition fœtale ou néonatale à une infection virale sont des événements qui prédisposent à certaines formes de schizophrénie. Il est possible de modéliser ces événements environnementaux chez des animaux et de produire certaines des caractéristiques de la schizophrénie, mais on n'a pas encore mis au point de modèles animaux qui englobent les aspects tant environnementaux que génétiques de cette maladie mentale. On a identifié un nombre important de gènes candidats pour la prédisposition à la schizophrénie qui encodent des protéines mises en cause dans la régulation de la plasticité synaptique, la neurotransmission, la migration des neurones, l'adhésion cellulaire, la transduction des signaux, le métabolisme de l'énergie et l'excroissance des neurites. Pour appuyer l'importance de ces processus dans la schizophrénie, les souris ayant des concentrations réduites ou complètement inexistantes des protéines qui contrôlent la neurotransmission glutamatergique, la migration des neurones, l'adhésion des cellules, la transduction des signaux, l'excroissance des neurites et la plasticité synaptique présentent de nombreuses caractéristiques qui rappellent la schizophrénie. Dans cette critique, nous discutons de stratégies de modélisation de la schizophrénie qui consistent à traiter des souris porteuses de ces mutations de diverses façons afin de mieux modéliser les facteurs tant environnementaux que génétiques à l'origine de cette maladie mentale complexe en fonction d'une « hypothèse double ». Comme les rongeurs peuvent exécuter des tâches cognitives complexes en se servant d'indices olfactifs mais non visuels ou auditifs, nous posons en hypothèse que des tests de performance cognitive fondés sur l'olfaction devraient servir à chercher des agents thérapeutiques nouveaux qui atténuent les déficits cognitifs caractéristiques de ce trouble mental dévastateur.
Similar articles
-
Mouse models of genetic effects on cognition: relevance to schizophrenia.Neuropharmacology. 2012 Mar;62(3):1204-20. doi: 10.1016/j.neuropharm.2011.04.025. Epub 2011 May 5. Neuropharmacology. 2012. PMID: 21557953 Review.
-
Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings.Schizophr Bull. 2007 Jan;33(1):11-5. doi: 10.1093/schbul/sbl063. Epub 2006 Nov 30. Schizophr Bull. 2007. PMID: 17138582 Free PMC article. Review.
-
Modeling combined schizophrenia-related behavioral and metabolic phenotypes in rodents.Behav Brain Res. 2015 Jan 1;276:130-42. doi: 10.1016/j.bbr.2014.04.016. Epub 2014 Apr 18. Behav Brain Res. 2015. PMID: 24747658 Review.
-
Insight across mental disorders: A multifaceted metacognitive phenomenon.Psychiatriki. 2019 Jan-Mar;30(1):13-16. doi: 10.22365/jpsych.2019.301.13. Psychiatriki. 2019. PMID: 31115349 English, Greek, Modern.
-
Neurocognitive and Perceptual Processing in Genetic Mouse Models of Schizophrenia: Emerging Lessons.Neuroscientist. 2019 Dec;25(6):597-619. doi: 10.1177/1073858418819435. Epub 2019 Jan 17. Neuroscientist. 2019. PMID: 30654694 Review.
Cited by
-
Obsessive-compulsive symptoms in patient with schizophrenia: The influence of disorganized symptoms, duration of schizophrenia, and drug resistance.Front Psychiatry. 2023 Feb 27;14:1120974. doi: 10.3389/fpsyt.2023.1120974. eCollection 2023. Front Psychiatry. 2023. PMID: 36923524 Free PMC article.
-
A Neurophysiological Perspective on a Preventive Treatment against Schizophrenia Using Transcranial Electric Stimulation of the Corticothalamic Pathway.Brain Sci. 2017 Mar 28;7(4):34. doi: 10.3390/brainsci7040034. Brain Sci. 2017. PMID: 28350371 Free PMC article. Review.
-
Validity and reliability of the Indonesian version of the Scale for the Assessment of Negative Symptoms.Front Psychiatry. 2023 Jan 20;13:1045635. doi: 10.3389/fpsyt.2022.1045635. eCollection 2022. Front Psychiatry. 2023. PMID: 36741563 Free PMC article.
-
Loss of STOP protein impairs peripheral olfactory neurogenesis.PLoS One. 2010 Sep 15;5(9):e12753. doi: 10.1371/journal.pone.0012753. PLoS One. 2010. PMID: 20856814 Free PMC article.
-
Behavioral changes and mitochondrial dysfunction in a rat model of schizophrenia induced by ketamine.Metab Brain Dis. 2011 Mar;26(1):69-77. doi: 10.1007/s11011-011-9234-1. Epub 2011 Feb 18. Metab Brain Dis. 2011. PMID: 21331561
References
-
- Seidman LJ, Talbot NL, Kalinowski AG, et al. Neuropsychological probes of fronto-limbic system dysfunction in schizophrenia. Olfactory identification and Wisconsin Card Sorting performance. Schizophr Res 1991;6:55-65. - PubMed
-
- Dickinson D, Iannone VN, Wilk CM, et al. General and specific cognitive deficits in schizophrenia. Biol Psychiatry 2004;55:826-33. - PubMed
-
- Kremen WS, Seidman LJ, Faraone SV, et al. Intelligence quotient and neuropsychological profiles in patients with schizophrenia and in normal volunteers. Biol Psychiatry 2001;50:453-62. - PubMed
-
- Andreasen NC. Symptoms, signs, and diagnosis of schizophrenia. Lancet 1995;346:477-81. - PubMed
-
- Andreasen NC. Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 1982;39:784-8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical